Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-04

Clinical Trial Update: Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium [NA]

View source ↗

Summary

This clinical trial evaluating pepsin versus Technetium-99m for diagnosing microaspiration in intubated critically ill patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pepsin (pepsin)
  • Technetium-99m (technetium-99m)

Snippet

Sponsor: University Hospital, Lille | Conditions: Critical Illness | NA | Status: WITHDRAWN